Amgen
AMGN
2,294 hedge funds and large institutions have $95.3B invested in Amgen in 2021 Q4 according to their latest regulatory filings, with 313 funds opening new positions, 875 increasing their positions, 847 reducing their positions, and 122 closing their positions.
157% more first-time investments, than exits
New positions opened: 313 | Existing positions closed: 122
12% more funds holding in top 10
Funds holding in top 10: 26 → 29 (+3)
8% more funds holding
Funds holding: 2,132 → 2,294 (+162)
6% more capital invested
Capital invested by funds: $90.2B → $95.3B (+$5.08B)
3% more repeat investments, than reductions
Existing positions increased: 875 | Existing positions reduced: 847
2% more call options, than puts
Call options by funds: $989M | Put options by funds: $974M
0.58% more ownership
Funds ownership: 74.76% → 75.34% (+0.58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$218M |
| 2 |
Barclays
London,
United Kingdom
|
+$208M |
| 3 |
Renaissance Technologies
New York
|
+$201M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$190M |
| 5 |
Canada Life
Winnipeg,
Manitoba, Canada
|
+$153M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$964M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$519M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$353M |
| 4 |
ClearBridge Investments
New York
|
-$195M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$176M |
AMGN Hedge Fund Activity: Q4 2021 in Review
2,294 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2021, worth a combined $95.3B — up 5.6% from $90.2B a quarter earlier.
Buyers outnumbered sellers: 313 funds opened new AMGN positions and 122 closed out — a net gain of 191 holders — while 875 added to existing stakes and 847 trimmed.
The largest buyer was BlackRock, adding an estimated $218M. The largest seller was Capital Research Global Investors, cutting an estimated $964M.
- 2,294 institutional investors held Amgen (AMGN) as of Q4 2021, up from 2,132 in Q3 2021.
- Funds reported $95.3B of Amgen stock for Q4 2021, up 5.6% quarter-over-quarter.
- 313 funds opened new Amgen positions in Q4 2021 and 122 closed out, a net change of +191 holders.
- The largest Amgen buyer in Q4 2021 was BlackRock, an estimated $218M added.
- The largest Amgen seller in Q4 2021 was Capital Research Global Investors, an estimated $964M sold.
Based on aggregated 13F filings for Q4 2021.